What blood tests are recommended for comprehensive STD screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive Blood Tests for STD Screening

Blood tests for STD screening should include serologic testing for syphilis, HIV, and hepatitis B, with additional tests based on risk factors and sexual practices. 1

Core Blood Tests for STD Screening

Essential Blood Tests:

  • Syphilis serology: Most laboratories use a reverse screening algorithm with treponemal-specific test first (EIA/chemiluminescence immunoassay) followed by nontreponemal test (RPR) for confirmation 2, 1
  • HIV antibody/antigen test: Recommended for all patients seeking STI evaluation 1
  • Hepatitis B surface antigen (HBsAg): Essential for comprehensive screening 2, 1

Additional Blood Tests Based on Risk:

  • Hepatitis C antibody: Particularly recommended for men who have sex with men (MSM) and those with risk factors 1
  • Type-specific HSV-2 serologic testing: Recommended for high-risk individuals, especially those with HIV infection or partners with genital herpes 1, 3

Testing Considerations by Population

High-Risk Individuals:

  • More frequent screening (every 3-6 months) for patients with:
    • Multiple or anonymous partners
    • Previous STI diagnosis
    • Substance use, especially methamphetamine
    • Sex work or partners who engage in sex work 1

Men Who Have Sex with Men (MSM):

  • All core blood tests plus:
    • Hepatitis C antibody screening
    • Type-specific HSV-2 serologic testing
    • Extragenital site testing (rectal, oropharyngeal) for gonorrhea and chlamydia 2, 1

Pregnant Women:

  • Serologic testing for syphilis during early pregnancy
  • Hepatitis B surface antigen testing
  • HIV testing at first prenatal visit and third trimester 2, 1

Important Clinical Considerations

Test Performance:

  • Syphilis serology sensitivity varies by stage:
    • Primary syphilis: 61-100% sensitivity
    • Secondary syphilis: 100% sensitivity
    • Late latent syphilis: 61-75% sensitivity 2

Common Pitfalls:

  1. Failing to screen partners: 25-40% of treatment "failures" are actually reinfections from untreated partners 2, 1
  2. Missing window periods: Recent infections may not be detectable immediately
  3. Overlooking extragenital infections: Testing only urogenital sites in high-risk individuals will miss infections at other sites 2, 1
  4. Biological false positives: Can occur with syphilis testing, particularly in patients with HIV, hepatitis B, or hepatitis C 2

Complementary Non-Blood Testing:

While not blood tests, comprehensive STD screening should also include:

  • Nucleic acid amplification tests (NAATs) for chlamydia, gonorrhea, and trichomonas on appropriate specimens (urine, vaginal/cervical swabs) 1, 4
  • Site-specific testing based on sexual practices (rectal, pharyngeal) 2, 1

Reporting Requirements

Positive tests for chlamydia, gonorrhea, syphilis, chancroid, and HIV require reporting to public health authorities according to local requirements 2, 1

Remember that blood tests are just one component of comprehensive STD screening. The combination of appropriate blood tests with nucleic acid amplification testing provides the most thorough approach to detecting sexually transmitted infections.

References

Guideline

Sexually Transmitted Infections Diagnosis and Screening

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recommendations for the selective use of herpes simplex virus type 2 serological tests.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.